EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: FINAL RESULTS FROM THE PHASE 3 U-ENDURE STUDY
Miguel Regueiro 1
Scott Lee 2
Raja Atreya 3
Efrat Broide 4
Cristina Rodriguez 5
Adriaan A. Van Bodegraven 6
Elena Dubcenco 7
Ana Paula Machado De Lacerda 7
Jianzhong Liu 7
Tian Feng 7
Ziqian Geng 7
Valencia Remple 7
Samuel Anyanwu 7
Julian Panés 8
1 Cleveland Clinic, Cleveland, United States
2 University of Washington Medical Center, Seattle, United States
3 Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
4 The Kamila Gonczarowski Institute of Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, Zerifin, Israel
5 University Hospital of Navarra, Pamplona, Spain
6 Zuyderland Medical Center, Herleen, Sittard-Geleen, Netherlands
7 AbbVie Inc., North Chicago, United States
8 Hospital Clinic Barcelona, IDIPABS, CIBERehd, Barcelona, Spain
Topic
IBD
Session
Hit the road JAK: Part 2
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]